Observational Analysis of Jake® Multimodal Data Collection System in Patients with Autism Spectrum Disorder
The Janssen Autism Knowledge Engine (JAKE) system, a digital phenotyping platform designed to measure and track Autism Spectrum Disorder (ASD) symptoms, has shown promising results in a recent study. The study, registered at clinicaltrials.gov (NCT02299700), was conducted over a prospective, observational period with 29 children and adolescents with ASD at three sites in the United States.
The study aimed to establish the feasibility of the JAKE system and learn practical aspects of its implementation. Data was collected using web, mobile, and wearable biosensor components in natural settings and laboratory tasks. Among the biosensors studied, the eye-tracker, sleep monitor, and electrocardiogram were shown to capture high-quality data, while wireless electroencephalography was found to be difficult to use due to its form factor.
The Autism Behavior Inventory (ABI), a parent-reported measure of ASD core and associated symptoms, performed well in the study. The majority of parents rated their overall reaction to JAKE as positive/very positive, and no significant device-related events were reported. The study's findings support the planning of refinements for all components of the JAKE system, and the results suggest that the JAKE system is safe for use in ASD clinical trials.
The JAKE system, after described changes, has been demonstrated to be viable for use in clinical trials of Autism Spectrum Disorder (ASD). Following the study, the JAKE system is considered a useful platform for ASD clinical trials. The results of the study justify larger validation and deployment studies of the optimized JAKE system.
For those seeking the most current information on JAKE’s development in biosensors and feasibility studies, it is recommended to consult peer-reviewed journals in autism research or official Janssen Pharmaceuticals communications and scientific presentations directly. The advancements in this area have focused on improving the feasibility, scalability, and accuracy of such biosensor approaches, but without updated or specific details on JAKE from the current search results, it is unclear what the very latest improvements or findings have been.
- The eye-tracking biosensor, along with the sleep monitor and electrocardiogram, was proven to provide high-quality data within the JAKE system, a platform designed for medical-conditions like Autism Spectrum Disorder (ASD), as part of a study focusing on health-and-wellness technology.
- As a result of the study's findings, the JAKE system, incorporating improvements in eye tracking, is considered a valuable tool for science-based research and potential clinical trials related to ASD, further highlighting its relevance in the field of health-and-wellness technology.
